Brief: Genmab Reports Q1 Operating Profit Of $180 Million
May 7 (Reuters) - Genmab A/S GMAB.CO: IS MAINTAINING ITS 2026 FINANCIAL GUIDANCE Q1 OPERATING PROFIT $180 MILLION VERSUS IBES ESTIMATE $184.7 MILLION Q1 REVENUE $896 MILLION VERSUS $890.4 MILLION SEEN IN LSEG POLL Q1 OPERATING EXPENSES, EXCLUDING ACQUISITION AND INTEGRATION RELATED CHARGES, WERE $606 MILLION Source text: ID:nGNE6Hgwh6 Further company coverage: GMAB.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos